The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2023 | Bone marrow infiltration in newly diagnosed DLBCL with primary/secondary CNSL
Central nervous system (CNS) involvement in diffuse large B-cell lymphoma (DLBCL) can be primary or secondary. Fernando Martin-Moro, MD, Ramón y Cajal University Hospital, Madrid, Spain, describes a comparison study of patients with newly diagnosed DLBCL with primary CNS lymphoma, secondary CNS lymphoma, or no CNS involvement. Dr Martin-Moro shares the findings of this comparison, highlighting that bone marrow infiltration did not occur in patients with DLBCL with primary CNS involvement, indicating that bone marrow assessment may be omitted for these patients. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
